13F HOLDINGS REPORT
DAFNA Capital Management LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001389933-23-000006
Total Value
$333.5M
Positions
72
Other Managers
1
Confidential Omitted
No
Holdings (72)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P BIOTECH ETF | 78464A870 | 570,000 | $43.4M | 13.02% |
| 2 | STEREOTAXIS INC | STXS | 13,680,554 | $27.9M | 8.37% |
| 3 | IVERIC BIO INC | 46583P102 | 612,975 | $14.9M | 4.47% |
| 4 | ASCENDIS PHARMA A/S | ASND | 135,212 | $14.5M | 4.35% |
| 5 | KARUNA THERAPEUTICS INC | 48576A100 | 78,573 | $14.3M | 4.28% |
| 6 | ISHARES NASDAQ BIOTECH INDX | 464287556 | 102,500 | $13.2M | 3.97% |
| 7 | REVOLUTION MEDICINES INC | RVMDW | 575,785 | $12.5M | 3.74% |
| 8 | BLUEPRINT MEDICINES CORP | 09627Y109 | 261,235 | $11.8M | 3.52% |
| 9 | XENON PHARMACEUTICALS INC | XENE | 316,092 | $11.3M | 3.39% |
| 10 | CYTOKINETICS INC | CYTK | 276,495 | $9.7M | 2.92% |
| 11 | SYNDAX PHARMACEUTICALS INC | SNDX | 447,073 | $9.4M | 2.83% |
| 12 | DEXCOM INC | DXCM | 67,552 | $7.8M | 2.35% |
| 13 | SAGE THERAPEUTICS INC | 78667J108 | 180,306 | $7.6M | 2.27% |
| 14 | NEUROCRINE BIOSCIENCES INC | NBIX | 74,615 | $7.6M | 2.26% |
| 15 | MORPHIC HOLDING INC | 61775R105 | 179,467 | $6.8M | 2.03% |
| 16 | IDEAYA BIOSCIENCES INC | IDYA | 468,358 | $6.4M | 1.93% |
| 17 | CARDIOVASCULAR SYSTEMS | 141619106 | 286,988 | $5.7M | 1.71% |
| 18 | DICE THERAPEUTICS INC | 23345J104 | 187,585 | $5.4M | 1.61% |
| 19 | VIKING THERAPEUTICS INC | VKTX | 319,155 | $5.3M | 1.59% |
| 20 | MERUS N V | N5749R100 | 283,998 | $5.2M | 1.57% |
| 21 | ATRICURE INC | ATRC | 125,529 | $5.2M | 1.56% |
| 22 | NURIX THERAPEUTICS INC | NRIX | 566,695 | $5.0M | 1.51% |
| 23 | EDGEWISE THERAPEUTICS INC | EWTX | 733,239 | $4.9M | 1.47% |
| 24 | KALVISTA PHARMACEUTICALS INC | KALV | 616,032 | $4.8M | 1.45% |
| 25 | BIOCRYST PHARMACEUTICALS INC | BCRX | 551,500 | $4.6M | 1.38% |
| 26 | ADICET BIO INC | ACET | 797,054 | $4.6M | 1.38% |
| 27 | CENTURY THERAPEUTICS INC | IPSC | 1,307,407 | $4.5M | 1.36% |
| 28 | APELLIS PHARMACEUTICALS INC | APLS | 57,746 | $3.8M | 1.14% |
| 29 | ALECTOR INC | ALEC | 592,438 | $3.7M | 1.10% |
| 30 | ACCURAY INC | ARAY | 1,222,358 | $3.6M | 1.09% |
| 31 | MEDIWOUND LTD | MDWD | 257,653 | $3.4M | 1.03% |
| 32 | BIOHAVEN LTD | BHVN | 235,613 | $3.2M | 0.96% |
| 33 | ARCUS BIOSCIENCES INC | RCUS | 175,217 | $3.2M | 0.96% |
| 34 | AXOGEN INC | AXGN | 332,103 | $3.1M | 0.94% |
| 35 | MIRATI THERAPEUTICS INC | 60468T105 | 73,600 | $2.7M | 0.82% |
| 36 | BICYCLE THERAPEUTICS PLC | BCYC | 122,200 | $2.6M | 0.78% |
| 37 | AUTOLUS THERAPEUTICS PLC | AUTL | 1,176,150 | $2.2M | 0.65% |
| 38 | MERSANA THERAPEUTICS INC | 59045L106 | 510,863 | $2.1M | 0.63% |
| 39 | GALAPAGOS NV | GLPGF | 52,675 | $2.0M | 0.61% |
| 40 | PROQR THERAPEUTICS N V | N71542109 | 940,582 | $2.0M | 0.60% |
| 41 | VIGIL NEUROSCIENCE INC | 92673K108 | 172,308 | $1.7M | 0.51% |
| 42 | KURA ONCOLOGY INC | KURA | 109,784 | $1.3M | 0.40% |
| 43 | ITEOS THERAPEUTICS INC | 46565G104 | 98,560 | $1.3M | 0.40% |
| 44 | THESEUS PHARMACEUTICALS INC | 88369M101 | 131,025 | $1.2M | 0.35% |
| 45 | LARIMAR THERAPEUTICS INC | LRMR | 236,873 | $1.1M | 0.32% |
| 46 | ORIC PHARMACEUTICALS INC | ORIC | 170,326 | $970,858 | 0.29% |
| 47 | ASTRIA THERAPEUTICS INC | 04635X102 | 69,883 | $929,444 | 0.28% |
| 48 | NEURONETICS INC | STIM | 313,717 | $912,916 | 0.27% |
| 49 | BRAINSWAY LTD | BRSYF | 473,981 | $831,837 | 0.25% |
| 50 | KEROS THERAPEUTICS INC | KROS | 19,361 | $826,715 | 0.25% |
| 51 | GENFIT S A | 372279109 | 197,940 | $811,554 | 0.24% |
| 52 | MEREO BIOPHARMA GROUP PLC | MREO | 1,096,513 | $775,125 | 0.23% |
| 53 | SURFACE ONCOLOGY INC | 86877M209 | 1,100,000 | $768,680 | 0.23% |
| 54 | KARYOPHARM THERAPEUTICS INC | KPTI | 192,678 | $749,517 | 0.22% |
| 55 | SYROS PHARMACEUTICALS INC | 87184Q206 | 265,878 | $709,894 | 0.21% |
| 56 | SPRUCE BIOSCIENCES INC | SPRB | 312,000 | $689,520 | 0.21% |
| 57 | ACRIVON THERAPEUTICS INC | ACRV | 51,148 | $649,068 | 0.19% |
| 58 | PARDES BIOSCIENCES INC | 69945Q105 | 479,386 | $632,790 | 0.19% |
| 59 | MASIMO CORP | MASI | 3,000 | $553,620 | 0.17% |
| 60 | KINNATE BIOPHARMA INC | 49705R105 | 81,008 | $506,300 | 0.15% |
| 61 | REGULUS THERAPEUTICS INC | 75915K309 | 555,555 | $470,833 | 0.14% |
| 62 | MEDICENNA THERAPEUTICS CORP | MDNAF | 660,000 | $415,536 | 0.12% |
| 63 | SUTRO BIOPHARMA INC | STRO | 84,700 | $391,314 | 0.12% |
| 64 | IKENA ONCOLOGY INC | 45175G108 | 112,936 | $389,629 | 0.12% |
| 65 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 351,064 | $382,660 | 0.11% |
| 66 | COMPASS THERAPEUTICS INC | CMPX | 116,882 | $382,204 | 0.11% |
| 67 | NEXTCURE INC | NXTC | 187,696 | $277,790 | 0.08% |
| 68 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 140,000 | $210,000 | 0.06% |
| 69 | INOGEN INC | INGN | 15,000 | $187,200 | 0.06% |
| 70 | SPERO THERAPEUTICS INC | SPRO | 125,000 | $181,250 | 0.05% |
| 71 | COMPUGEN LTD | CGEN | 205,202 | $144,052 | 0.04% |
| 72 | REUNION NEUROSCIENCE INC | 76134G103 | 12,598 | $8,698 | 0.00% |